Featured Firms
Presented by BigVoodoo
In a case closely watched by the biotech industry, the U.S. Court of Appeals for the Federal Circuit has refused to review en banc a ruling against the University of Rochester in its patent battle over rights to a multibillion-dollar painkiller. At issue is whether a patent can be held invalid if it does not provide a "written description" of the invention. The 7 to 5 decision revealed a sharp divide that lawyers say requires action by the U.S. Supreme Court.
July 08, 2004 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS